FOOD AND DRUG ADMINISTRATION

First Page		Document Content
Date: 2008-11-21 11:05:15 Opioid antagonists Phenols Alcohols Morphinans Opiates Morphine/naltrexone Naltrexone Center for Drug Evaluation and Research Food and Drug Administration Chemistry Organic chemistry Pharmacology		FOOD AND DRUG ADMINISTRATION Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 35,31 KB Share Document on Facebook

	Key Techniques to Reduce Severe Injection Site Reactions ® VIVITROL (naltrexone for extended-release injectable suspension) Intramuscular Injection • Use appropriate VIVITROL needle to ensure the injection reaches the DocID: 1uZFA - View Document
	MEDICATION GUIDE VIVITROL® (viv-i-trol) (naltrexone for extended-release injectable suspension) Read this Medication Guide before you start receiving VIVITROL injections and each time you receive an injection. There may DocID: 1udj5 - View Document
	Contrave Contrave is a new medication which has been approved by the FDA for weight loss. It is a combination of naltrexone (Vivitrol, Revia) and bupropion (Wellbutrin). It contains a black box warning for suicidal thoug DocID: 1u1gu - View Document
	ATION ASSISTED TREATMENT• BUPRENORPHINE• NALTREXONE• MEDICATION ASSISTED TREATMENT• BUPRENORPHINE• NALTREXONE• MED SISTED TREATMENT• BUPRENORPHINE• NALTREXONE• MEDICATION ASSISTED TREATMENT• BUPRENOR DocID: 1tG05 - View Document
	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CONTRAVE® safely and effectively. See full prescribing information for CONTRAVE. CONTRAVE (naltrexone HCl and bupro DocID: 1sTJs - View Document